In The News
ScienceDirect.com
April 2024
​
Psilocybin eases burnout and depression, UW study finds
Axios.com
Dec 5, 2024
US soldiers to be given ecstasy drug in PTSD trial
TheTimes.com
March 21 2025
MDMA’s Latest Trial Results Offer Hope for Patients with PTSD
UCSF
September 18, 2023
​
Can An Experimental Drug Rewire the Brain to Treat Parkinson’s?
Columbia University
November 26, 2024
​
Silo Pharma Plans Phase 2B Trial Testing Low-dose Psychedelics in Parkinson’s
ParkinsonsNewsToday.com
December 4, 2020
​
Looking Into Psychedelics for Alzheimer's Research
BrainFacts.org
13 Dec 2022
​
Far Out: New Psychedelic for Alzheimer’s Depression Heads to Trials
Being Patient.com
September 20th, 2022
Bein
Ground-breaking LSD Microdosing for Alzheimer’s Study
The Beckley Foundation
2025
Phase 2 Study of COMP360 Psilocybin Finds Improved PTSD Symptoms
Psychiatric Times
May 9, 2024
Medical Uses and Adverse Effects of Psilocybin
Psychiatrist.com
May 28, 2024
The Role of Set and Setting in Psilocybin Therapy for Trauma
Changa Institute
Jan 16, 2025
​​
Science Direct
May 2024
​
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial
Nature Medicine
September 14, 2023
​
Psilocybin for Trauma-Related Disorders
National Institute of Health
2022
​
Psilocybin Spurs Brain Activity in Patients With Depression, Small Study Shows
APRIL 11, 2022
​​
​​
Microdosed LSD: Finally A Breakthrough For Alzheimer’s Disease?
Forbes
Feb 21, 2020